BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial
SUNNYVALE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP® Cell Therapy Heart Failure Trial (clinicaltrials.gov Identifier: […]
Orchard Therapeutics Announces Multiple Presentations at 2022 SSIEM Annual Symposium Highlighting Neurometabolic Disease Portfolio
BOSTON and LONDON, Aug. 29, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced seven presentations from across its neurometabolic portfolio will be featured at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium, taking place from August 30 to September 2, 2022, in Freiburg, […]
Combining Synthetic and Stem Cell Biology
Mark Kotter discusses how software-inspired approach to synthetic biology facilitates the targeting and reprogramming of entire sets of stem cells into other human cell types. By combining synthetic and stem cell biology, Mark and his team at bit.bio are providing stable supplies of human cell types for research and drug discovery. Video Transcript: (soft music) […]
What about Stem Cell Banking? Answers to Cord Blood Banking FAQs & More
Have you heard about cord blood banking, but aren’t quite sure what it is or why you’d want to consider it? Catch a news story about celebrities using regenerative stem cells and wonder what’s the big deal? This is the video for you! Benefits, Risks, and Alternatives of Stem Cell Collection BENEFITS – Security that […]
Can stem cells shape the future of medicine? | Esther Wolfs
At this very moment, research is being done on Charcot-Marie-Tooth disease type 1A. Esther is a leading researcher in this field and will tell you more about how cancer and other global diseases can be cured using this new technique. Esther uses stem cells in anticancer therapy and as a model to study Charcot-Marie-Tooth disease […]
STEM CELLS: Totipotent, pluripotent, multipotent and unipotent
Learn the different types of stem cells for A-level biology. What the properties are and where these stem cells can be sourced. What are the pros and cons of using pluripotent stem cells in medicine and how might iPS cells be better. Video Transcript: Hi there and welcome to Learn A-Level Biology for free with […]
Harnessing Stem Cells to Treat Disease
Thanks to advances in techniques for culturing and genetically modifying patient cells, scientists developed myriad stem cell-based treatments for human diseases. Therapeutic success rates for stem cell-based treatments depend on whether scientists can provide the proper structural and molecular cues to form the cell types lacking in patients. In addition, to support successful engraftment, researchers […]
Immunis Announces FDA Clearance and Clinical Site for Phase 1/2a Clinical Trial Investigating Immune-Mediated Muscle Atrophy
IRVINE, Calif., Aug. 9, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, today announced that the U.S. Food and Drug Administration has approved it’s Investigational New Drug application for a Phase 1/2a clinical trial investigating IMM01-STEM in participants with muscle atrophy: www.clinicaltrials.gov/ct2/show/NCT05211986 The open label […]
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
EDINBURGH, UK AND HOPKINTON, MA, 4 August 2022 – RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation (‘CDMO’) developing life-changing therapies in Edinburgh’s BioQuarter, and Lykan Bioscience (‘Lykan’), an innovative CDMO focused on cell-based therapies, today announce that they have entered into a business combination agreement to form a global leading innovative […]
TransCode Therapeutics and MD Anderson Announce Strategic Alliance to Advance RNA Therapies for Oncology
BOSTON and HOUSTON, Aug. 02, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA oncology company, and The University of Texas MD Anderson Cancer Center (“MD Anderson”), today announced a strategic alliance to advance TransCode’s pipeline of RNA-targeted oncology therapeutic and diagnostic candidates. Through the alliance, TransCode and MD […]